Jazz Pharmaceuticals PLC Capital Reinvestment Ratio
Jazz Pharmaceuticals PLC capital reinvestment ratio. Jazz Pharmaceuticals PLC (JAZZ) has a Capital Reinvestment Ratio of 0.05x as of March 2026, meaning it reinvests 0% of its operating cash flow ($408.20 Million) in capital expenditures ($19.70 Million). Check Jazz Pharmaceuticals PLC (JAZZ) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jazz Pharmaceuticals PLC (2010–2025)
Capital reinvestment ratio of Jazz Pharmaceuticals PLC from 2010 to 2025. This chart tracks Jazz Pharmaceuticals PLC's Capital Reinvestment Ratio across 16 annual periods. Also explore Jazz Pharmaceuticals PLC annual equity growth to track the company's year-over-year net asset growth rate.
Jazz Pharmaceuticals PLC Capital Reinvestment Ratio by Year (2010–2025)
Jazz Pharmaceuticals PLC capital reinvestment ratio by year from 2010 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Jazz Pharmaceuticals PLC.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $1.36 Billion | $58.75 Million | ▲ +25.8% |
| 2024 | 0.03x | $1.40 Billion | $48.07 Million | ▲ +56.9% |
| 2023 | 0.02x | $1.09 Billion | $23.96 Million | ▼ -94.4% |
| 2022 | 0.39x | $1.27 Billion | $498.19 Million | ▲ +569.7% |
| 2021 | 0.06x | $778.51 Million | $45.53 Million | ▼ -86.1% |
| 2020 | 0.42x | $899.65 Million | $379.25 Million | ▲ +79.5% |
| 2019 | 0.23x | $776.40 Million | $182.34 Million | ▲ +42.7% |
| 2018 | 0.16x | $798.90 Million | $131.47 Million | ▲ +0.1% |
| 2017 | 0.16x | $693.09 Million | $113.95 Million | ▼ -46.5% |
| 2016 | 0.31x | $590.54 Million | $181.58 Million | ▲ +354.9% |
| 2015 | 0.07x | $531.94 Million | $35.96 Million | ▼ -88.5% |
| 2014 | 0.59x | $405.76 Million | $238.97 Million | ▲ +1381.3% |
| 2013 | 0.04x | $283.62 Million | $11.28 Million | ▼ -55.8% |
| 2012 | 0.09x | $249.75 Million | $22.48 Million | ▲ +136.1% |
| 2011 | 0.04x | $151.60 Million | $5.78 Million | ▼ -52.6% |
| 2010 | 0.08x | $58.87 Million | $4.73 Million | — |